IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — OncoCyte Corp. (OCX) on Monday reported a loss of $33.5 million in its fourth quarter.
The Irvine, California-based company said it had a loss of $1.93 per share. Earnings, adjusted for asset impairment costs, came to 48 cents per share.
The cancer diagnostic test developer posted revenue of $1.5 million in the period.
For the year, the company reported a loss of $60.9 million, or $4.66 per share. Revenue was reported as $1.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCX at https://www.zacks.com/ap/OCX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
